28.8 MB (4.4 MB compressed)
2811 x 3580 pixels
23.9 x 30.2 cm ⏐ 9.4 x 11.9 in (300dpi)
DNA ILLUSTRATIONS / SCIENCE SOURCE / SCIENCE PHOTO LIBRARY DNA ILLUSTRATIONS / SCIENCE SOURCE / SCIENCE PHOTO LIBRARY
There are limited treatment options of a rare form of adult leukaemia (Acute Lymphoblastic Leukaemia, ALL) for patients with relapsed or refractory Philadelphia chromosome negative (ph-) ALL. Blinatumomab is first in a class of immunotherapy agents called a bispecific T cell-engager (BiTE) antibody. The two antigens targeted by the bispecific design is CD3 which is found on cytotoxic T cell, and CD19 which is found on B lymphocytes throughout their development.
Model release not required. Property release not required.